Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation

ClinicalTrials.gov ID: NCT01007123

Public ClinicalTrials.gov record NCT01007123. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 11:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb, Double-blind, Randomised, Placebo-controlled, Multi-centre, Dose-finding Efficacy and Safety Study of a Range of Doses of Elobixibat in Patients With Chronic Idiopathic Constipation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with chronic idiopathic constipation.

Study identification

NCT ID
NCT01007123
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Albireo
Industry
Enrollment
190 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
20 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2009 (Type not available)
Primary completion
Oct 2010 (Actual)
Completion
Oct 2010 (Actual)
Last update posted
Mar 22, 2017

2009 – 2010

United States locations

U.S. sites
44
U.S. states
25
U.S. cities
43
Facility City State ZIP Site status
Albireo Investigative Site Huntsville Alabama 35801 —
Albireo Investigative Site Chandler Arizona 85224 —
Albireo Investigative Site Phoenix Arizona 85020 —
Albireo Investigative Site Anaheim California 92801 —
Albireo Investigative Site Encinitas California 92024 —
Albireo Investigative Site San Diego California 92108 —
Albireo Investigative Site Colorado Springs Colorado 80904 —
Albireo Investigative Site Boynton Beach Florida 33426 —
Albireo Investigative Site Inverness Florida 34452 —
Albireo Investigative Site Peoria Illinois 61602 —
Albireo Investigative Site Clive Iowa 50325 —
Albireo Investigative Site Davenport Iowa 52807 —
Albireo Investigative Site Mission Kansas 66202 —
Albireo Investigative Site Overland Park Kansas 66215 —
Albireo Investigative Site Monroe Louisiana 71201 —
Albireo Investigative Site Shreveport Louisiana 71103 —
Albireo Investigative Site Annapolis Maryland 21401 —
Albireo Investigative Site Baltimore Maryland 21215 —
Albireo Investigative Site Hollywood Maryland 20636 —
Albireo Investigative Site Chesterfield Michigan 48047 —
Albireo Investigative Site Henderson Nevada 89104 —
Albireo Investigative Site Marlton New Jersey 08053 —
Albireo Investigative Site Albuquerque New Mexico 87108 —
Albireo Investigative Site Great Neck New York 11021 —
Albireo Investigative Site Charlotte North Carolina 28211 —
Albireo Investigative Site Greensboro North Carolina 27408 —
Albireo Investigative Site Harrisburg North Carolina 28075 —
Albireo Investigative Site Statesville North Carolina 28625 —
Albireo Investigative Site Winston-Salem North Carolina 27103 —
Albireo Investigative Site Cincinnati Ohio 45224 —
Albireo Investigative Site Cincinnati Ohio 45242 —
Albireo Investigative Site Dayton Ohio 45440 —
Albireo Investigative Site Oklahoma City Oklahoma 73116 —
Albireo Investigative Site Levittown Pennsylvania 19056 —
Albireo Investigative Site Anderson South Carolina 29621 —
Albireo Investigative Site Chattanooga Tennessee 37411 —
Albireo Investigative Site Kingsport Tennessee 37660 —
Albireo Investigative Site El Paso Texas 79905 —
Albireo Investigative Site Longview Texas 75605 —
Albireo Investigative Site San Antonio Texas 78229 —
Albireo Investigative Site Ogden Utah 84405 —
Albireo Investigative Site Salt Lake City Utah 84107 —
Albireo Investigative Site Lynchburg Virginia 24502 —
Albireo Investigative Site La Crosse Wisconsin 54601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01007123, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 22, 2017 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01007123 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →